IPO registrations (S-1, F-1) · Registrants
TAMIR BIOTECHNOLOGY, INC.
- SEC CIK
- 708717 · filings on EDGAR ↗
- Former names
- Tamir Biotechnology, Inc. (2010–2016); ALFACELL CORP (1995–2010)
- Registration
- Form S-1, first filed 2000-05-31, last 2010-04-30; 5 initial registrations, 8 amendments
- Outcome
- Final prospectus filed 2002-06-06; declared effective 2006-08-25; withdrawal requested 2011-03-15
- Industry (SIC)
- Biological Products, (No Diagnostic Substances) 2836
- Incorporated in
- DE
- Business address
- 51 JFK PARKWAY, 1ST FLOOR WEST, STE 108, Short Hills, NJ 07078
- EIN
- 22-2369085
- EDGAR entity type
- operating
- Insiders and CEO pay
- TAMIR BIOTECHNOLOGY, INC. on the corporate pages
Offering terms
- Shares offered
- 3,077,276
- Listing
- OTC under the symbol ACEL.OB
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Form 5500 plan sponsor: TAMIR BIOTECHNOLOGY, INC. EXACT (EIN (EXACT))
- Form D issuer: TAMIR BIOTECHNOLOGY, INC. EXACT (CIK (EXACT))
- SEC filer: ALFACELL CORP EXACT (CIK (EXACT))
Filings 20
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2000-05-31 | S-1 | S-1 (registration) | ALFACELL CORP | 0000891554-00-001523 ↗ |
| 2000-07-03 | S-1/A | S-1/A (amendment) | ALFACELL CORP | 0000891554-00-001691 ↗ |
| 2001-07-30 | S-1/A | S-1/A (amendment) | ALFACELL CORP | 0000891554-01-503711 ↗ |
| 2001-12-14 | S-1/A | S-1/A (amendment) | ALFACELL CORP | 0000891554-01-506919 ↗ |
| 2002-02-21 | S-1/A | S-1/A (amendment) | ALFACELL CORP | 0000891554-02-000946 ↗ |
| 2002-05-24 | S-1 | S-1 (registration) | ALFACELL CORP | 0000891554-02-003666 ↗ |
| 2002-06-03 | S-1/A | S-1/A (amendment) | ALFACELL CORP | 0000891554-02-003758 ↗ |
| 2002-06-06 | 424B1 | 424B1 (final prospectus) | ALFACELL CORP | 0000891554-02-003780 ↗ |
| 2003-03-11 | 424B1 | 424B1 (final prospectus) | ALFACELL CORP | 0001169232-03-002025 ↗ |
| 2003-03-11 | 424B1 | 424B1 (final prospectus) | ALFACELL CORP | 0001169232-03-002026 ↗ |
| 2003-12-11 | S-1 | S-1 (registration) | ALFACELL CORP | 0001169232-03-007017 ↗ |
| 2004-01-07 | S-1/A | S-1/A (amendment) | ALFACELL CORP | 0001169232-04-000066 ↗ |
| 2004-01-08 | 424B1 | 424B1 (final prospectus) | ALFACELL CORP | 0001169232-04-000088 ↗ |
| 2004-02-17 | S-1 | S-1 (registration) | ALFACELL CORP | 0001169232-04-001047 ↗ |
| 2004-05-18 | S-1/A | S-1/A (amendment) | ALFACELL CORP | 0001169232-04-003032 ↗ |
| 2004-08-16 | S-1/A | S-1/A (amendment) | ALFACELL CORP | 0001169232-04-004121 ↗ |
| 2004-08-26 | 424B1 | 424B1 (final prospectus) | ALFACELL CORP | 0001169232-04-004681 ↗ |
| 2006-08-25 | EFFECT | EFFECT (declared effective) | ALFACELL CORP | 9999999995-06-001342 ↗ |
| 2010-04-30 | S-1 | S-1 (registration) | Tamir Biotechnology, Inc. | 0001437749-10-001303 ↗ |
| 2011-03-15 | RW | RW (withdrawal request) | Tamir Biotechnology, Inc. | 0001387131-11-000352 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2002-06-03 | S-1/A | registration statement | 3,077,276 | - | OTC ACEL.OB | 0 | primary document; shares headline | document ↗ | ||
| 2002-06-06 | 424B1 | final prospectus | 3,077,276 | - | OTC ACEL.OB | 0 | primary document; shares headline | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| BRANCACCIO JOHN P | Director | 11 | 2006–2012 | ||
| CARTER STEPHEN | Director | 6 | 2006–2009 | ||
| CONKLIN DONALD R | Director | 7 | 2006–2009 | ||
| LOUGHLIN JAMES J | Director | 6 | 2006–2009 | ||
| SIDRANSKY DAVID | Director | 9 | 2006–2012 | ||
| WEISS PAUL M | Director | 10 | 2006–2012 | ||
| McCash Family Limited Partnership | TenPercentOwner | 6 | 2006–2007 | ||
| SHOGEN KUSLIMA | Director,Officer | CEO | 12 | 2006–2008 | |
| Love Robert Dennis | Officer | Chief Financial Officer | 2 | 2006 | |
| KENYON LAWRENCE A | Officer | CEO, CFO; EVP, CFO and Secretary; President, CEO and CFO | 5 | 2007–2012 | |
| Knoll Capital Management, LP | TenPercentOwner | 2 | 2008–2012 | ||
| KNOLL FRED | TenPercentOwner | 2 | 2008–2012 | ||
| MUNIZ CHARLES | Director,Officer | President, CEO and CFO; President, COO and CFO | 2 | 2009 | |
| EUROPA INTERNATIONAL INC | TenPercentOwner | 1 | 2012 | ||
| Sulley Jamie Marie | Director,Officer | President | 2 | 2013 | |
| Barsa Joanne Marie | Officer | Chief Financial Officer | 1 | 2013 | |
| Ostronic Francis Patrick | Director | 1 | 2013 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2018-01-25 | TAMIR BIOTECHNOLOGY, INC. | Biotechnology | $1,500,000 | $808,638 | 3 | 1 |
| 2016-05-20 | Tamir Biotechnology, Inc. | Biotechnology | $1,722,476 | $1,722,476 | 9 | 2 |
| 2015-09-10 | Tamir Biotechnology, Inc. | Biotechnology | $800,000 | $800,000 | 7 | 1 |
| 2014-05-07 | Tamir Biotechnology, Inc. | Biotechnology | Indefinite | $850,312 | 9 | 2 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Form D issuer | TAMIR BIOTECHNOLOGY, INC. | NJ | Form D private offerings | CIK (EXACT) |
| SEC filer | Tamir Biotechnology, Inc. | SEC filers (EDGAR) | CIK (EXACT) | |
| Form 5500 plan sponsor | TAMIR BIOTECHNOLOGY, INC. | EIN (EXACT) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Biological Products, (No Diagnostic Substances), NJ first:
- IGX CORP/DE NJ
- ADMA BIOLOGICS, INC. NJ
- Point of Care Nano-Technology, Inc. NJ
- Outlook Therapeutics, Inc. NJ
- Oyster Point Pharma, Inc. NJ
- Kalaris Therapeutics, Inc. NJ
- Tevogen Inc. NJ
- GENTA INC DE/ NJ
- BioNTech SE 2M
- Immatics N.V. 2M
In other datasets, the same topic (Health) in NJ:
- Nonprofit: 1ST CEREBRAL PALSY OF NEW JERSEY INC (Nonprofits (IRS Form 990))
Interests: Biological Products, (No Diagnostic Substances) · Health